Sinopharm Tech Holdings (HKSE:08156) PEG Ratio: N/A (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08156 Sinopharm Tech Holdings Ltd HKSE:08156
27 GF Score
Price HK$0.16
GF Value HK$0.06
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sinopharm Tech Holdings PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Sinopharm Tech Holdings's PE Ratio without NRI is 0.00. Sinopharm Tech Holdings's 5-Year EBITDA growth rate is 0.00%. Therefore, Sinopharm Tech Holdings's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Sinopharm Tech Holdings's PEG Ratio or its related term are showing as below:


During the past 13 years, Sinopharm Tech Holdings's highest PEG Ratio was 0.02. The lowest was 0.01. And the median was 0.01.


HKSE:08156's PEG Ratio is not ranked *
in the Software industry.
Industry Median: 1.31
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Sinopharm Tech Holdings  (HKSE:08156) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Sinopharm Tech Holdings PEG Ratio Related Terms


Sinopharm Tech Holdings PEG Ratio Historical Data

* Premium members only.

The historical data trend for Sinopharm Tech Holdings's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinopharm Tech Holdings PEG Ratio Chart

Sinopharm Tech Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.02 0.00 0.00

Sinopharm Tech Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.00 0.00 0.00

HKSE:08156 vs QH, SHOP, UBER: PEG Ratio Comparison

For the Software - Application subindustry, Sinopharm Tech Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings PEG Ratio vs Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's PEG Ratio falls into.


HKSE:08156
27GF Score
Sinopharm Tech Holdings Ltd HKSE:08156
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinopharm Tech Holdings PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Sinopharm Tech Holdings's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Sinopharm Tech Holdings (HKSE:08156) Overvalued in 2026?

Based on GuruFocus' analysis, Sinopharm Tech Holdings stock appears to be overvalued. The current stock price of HK$0.16 is trading 160% above its estimated GF Value™ of HK$0.06. GuruFocus considers Sinopharm Tech Holdings to be Significantly Overvalued.

Key valuation signals for HKSE:08156:

  • PEG Ratio: N/A
  • GF Value™: HK$0.06 vs. price of HK$0.16 (160% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the HKSE:08156 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sinopharm Tech Holdings Business Description

Address Ruttonjee Centre, 11 Duddell Street Central, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company operating through three segments: Internet Plus services, Supply Chain services, and Manufacturing and distribution of personal protective equipment. The company generates the majority of its revenue from the Supply Chain services segment, which includes supply chain management, data analysis, and trading of medical and related products. Geographically, it operates in Hong Kong and the People's Republic of China (PRC), with the majority of its revenue coming from the PRC.
27GF Score

Get the complete analysis for HKSE:08156

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.06
GF Value